
Conference Coverage
18 days ago
Hernexeos Effective in HER2-Mutated NSCLCLatest Content

FDA Approves First Interchangeable Biosimilar to Perjeta in HER2+ Breast Cancer

FDA Grants Drug Designation to Tinostamustine for Malignant Glioma

FDA Approves Komzifti for NPM1-Mutant Acute Myeloid Leukemia

Experts Highlight Notable Advances in Colorectal Cancer at 2025 ESMO

Cancer Experts Share Emerging Treatments Patients Should Know in 2026

Shorts






Podcasts
Videos
All News

After her own breast cancer treatment, Maureen advocated for legislation to make scalp cooling more accessible for patients seeking to preserve their hair.

For Maureen Green, scalp cooling was a crucial part of her breast cancer treatment journey, as it prevented chemotherapy-induced hair loss.

A survivor shares how hearing loss and cancer deepened her grief, leading her to confront denial and embrace support from her church community.

Ten years after first being diagnosed with breast cancer, Cynthia Malaran said she still faces some side effects from treatment, but she has found strategies for coping.

Trial data showed a 62% complete response rate at 6 months with detalimogene coraplasmid among patients with high-risk, BCG-unresponsive bladder cancer.

Tracy Milgram-Posner sat down for an interview with CURE to discuss BRCAStrong and the impact she hopes to make for anyone with breast cancer.

A breast cancer survivor and mother discusses the importance of prioritizing her own needs.

Dr. Joshua Sabari, Dr. Petros Grivas, and Dr. Chandler Park discuss new developments in perioperative therapy for muscle-invasive bladder cancer.

Dr. Minetta Liu explains how Signatera detects tumor DNA after bladder surgery, guiding treatment and identifying patients who need immunotherapy.

During my cancer journey, anticipatory anxiety made me ask “what if” questions, but reframing them with hope helped me stay positive and improve my chances of surviving.

Dr. Suneel Kamath sat down for Pancreatic Cancer Awareness Month to discuss advances in treatment and the importance of raising awareness for this disease.

MB-105 received a special FDA status to help deliver faster treatment options for people with relapsed T-cell lymphoma who have few options.

Four-time non-Hodgkin lymphoma survivor Shell Rowe knows very well about the importance of finding the lighthearted side of an otherwise serious situation.

While cancer patients can experience ghosting, and cancer ghosting is real, it is possible to revisit relationships to avoid putting blaming the person who appears to be slipping away.

Dave Nitsche, a nonsmoker and endurance athlete, pushes back against stigma and stays active while advocating for lung cancer screening.





















